M. Nakane et al., Disseminated toxoplasmosis after CD34(+)-selected autologous peripheral blood stem cell transplantation, HAEMATOLOG, 85(3), 2000, pp. 334-335
A patient with adult T-cell leukemia/lymphoma was successfully treated by a
utologous CD34(+) peripheral blood stem cell transplantation (PBSCT) after
fractionated total body irradiation (TBI) and high-dose cytarabine and cycl
ophosphamide. However, the combination of CD34(+) cell-selected PBSCT and T
BI regimen resulted in a delayed immune-cell reconstitution and rendered th
e patient susceptible to disseminated toxoplasmosis.